By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Synthetic Genomics, Inc. 

11149 North Torrey Pines Road

La Jolla  California  92037  U.S.A.
Phone: 858-754-2900 Fax: 858-754-2988


Synthetic Genomics Inc. was founded to commercialize genomic-driven technologies. Our scientific strength lies in the decades of pioneering research by founders, J. Craig Venter, Ph.D., Nobel Laureate Hamilton O. Smith, M.D., and the leading scientific teams they have assembled. Dr. Venter and his teams have proven track records of making scientific breakthroughs that translate into viable commercial solutions.

The company's scientific capabilities encompass areas such as environmental genomics, microbiology, biochemistry, bioinformatics, plant genomics, genome engineering, synthetic biology, and climate change. In addition to the strong applied research efforts conducted at SGI, the company sponsors fundamental research at the J. Craig Venter Institute, a not-for-profit organization with more than 400 scientists and staff working on a variety of genomic research and policy fronts. In addition to the Intellectual Property developed internally, SGI has exclusive access to new inventions and discoveries in synthetic genomics research developed by the JCVI under the Sponsored Research Agreement between both organizations.

Key Statistics

Ownership: Private

Web Site: Synthetic Genomics, Inc.


Start Up

Company News
Synthetic Genomics, Inc. Expands Collaborative Research And Development Agreement With Lung Biotechnology PBC, A Subsidiary Of United Therapeutics (UTHR), To Develop Organs For Transplantation 9/23/2015 11:21:46 AM
Synthetic Genomics, Inc. And Gen9 Sign Licensing Agreement For Synthetic Biology Technology Patents 6/11/2015 11:27:08 AM
Synthetic Genomics, Inc. Release: SGI-DNA Launches Gibson Assembly® Ultra Kit For Robust, Seamless And Efficient Construction Of Synthetic Genes, Genetic Pathways And Whole Genomes 1/21/2015 11:12:20 AM
Synthetic Genomics, Inc. Appoints Oliver Fetzer, Ph.D., MBA As Chief Executive Officer 10/28/2014 6:12:17 AM
Avoca Signs Supply Agreement With Synthetic Genomics, Inc. To Become Domestic Source Of Natural Astaxanthin 6/20/2014 8:20:20 AM
Synthetic Genomics, Inc. Research Team Publishes New Methods for Synthetic Generation of Influenza Vaccines 5/16/2013 9:44:46 AM
SGI-DNA, a New Subsidiary of Synthetic Genomics, Inc., and Integrated DNA Technologies Announce Broader Collaboration to Develop, Manufacture, and Market Synthetic DNA Products 2/27/2013 10:13:57 AM
New England Biolabs, Inc. and Synthetic Genomics, Inc. Introduce the Gibson Assembly™ Cloning Kit, a Revolutionary New Approach to DNA Cloning 12/13/2012 9:22:39 AM
Synthetic Genomics, Inc. Purchases Patent Portfolio From Febit, Inc. 9/18/2012 10:09:59 AM
Synthetic Genomics, Inc. Purchases 81 Acre Site in South California Desert for Scale up and Testing of Innovative Algae Strains 5/25/2012 10:14:03 AM